Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Curebase

Explore full profile

Provider of decentralized clinical research software solutions and services to patients and medical providers

San Francisco, United StatesFounded 2017Health Tech & Medtech
Valuation $100–250M Last recorded · 2022
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Curebase and the history behind them.

About Curebase

Curebase operates in the clinical trials industry, providing innovative software solutions designed to enhance patient engagement and data accuracy. The company serves pharmaceutical companies, medical device manufacturers, and contract research organizations (CROs) by offering a suite of tools including ePRO (electronic Patient-Reported Outcomes), eCOA (electronic Clinical Outcome Assessments), eConsent, and EDC (Electronic Data Capture). These tools are highly configurable, allowing for rapid study launches and optimized participant experiences. Curebase's business model revolves around licensing its software to clients, who use it to streamline their clinical trials, improve data quality, and ensure regulatory compliance. Revenue is generated through subscription fees and service contracts. The company operates in a competitive market but differentiates itself with its focus on user-friendly design and robust data collection capabilities.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
San Francisco, United States
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A9 investors entered at this stage

Series B and later7 investors entered at this stage

Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States57.1%
🇧🇷 Brazil11.9%
🇳🇮 Nicaragua9.5%
🇨🇦 Canada7.1%
🇬🇹 Guatemala2.4%
Top 5 of 9 shown
Web traffic by country
6.9K monthly visits
across markets
🇺🇸 United States50.7%
🇬🇧 United Kingdom18.8%
🇮🇳 India14.5%
🇵🇹 Portugal11.6%
🇨🇦 Canada2.9%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Curebase on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Curebase on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.